-
Value proposition
Creating a new path for neurodegenerative diseases
Tetraneuron is a drug discovery company, focused on the development of a disruptive gene therapy for Alzheimer’s Disease (AD) and an Early Biomarker for this neurodegenerative condition.
alzheimer, terapia genica, gene therapy , disruptive therapy, Alzheimer´s Disease, Biomarker, neurodegenerative disease, neuroscience, neurociencia, enfermedades neurodegenerativas, neurodegeneration, dementia, and pioneering
-
Tetraneuron – A new path for neurodegenerative diseases
https://www.tetraneuron.com
| Catalyst | Type | Tweets | Articles | |
|---|---|---|---|---|
ICEX
Event, International Trade and Development (Auto) |
ICEX
Event, International Trade and Development (Auto) |
Other
15 Oct 2026 |
|
|
Eurostat
European Union, Government Administration (Auto) |
Eurostat
European Union, Government Administration (Auto) |
Other
20 Oct 2026 |
|
|
Comunidad de Madrid
National and local authorities, Government Administration (Auto) |
Comunidad de Madrid
National and local authorities, Government Administration (Auto) |
Other
9 Jun 2026 |
|
|
Indra Group
Defense and Space Manufacturing (Auto) |
Indra Group
Defense and Space Manufacturing (Auto) |
Other
4 Apr 2026 |
|
|